Page last updated: 2024-10-23

benzo(a)pyrene and Cockayne Syndrome

benzo(a)pyrene has been researched along with Cockayne Syndrome in 1 studies

Benzo(a)pyrene: A potent mutagen and carcinogen. It is a public health concern because of its possible effects on industrial workers, as an environmental pollutant, an as a component of tobacco smoke.
benzo[a]pyrene : An ortho- and peri-fused polycyclic arene consisting of five fused benzene rings.

Cockayne Syndrome: A syndrome characterized by multiple system abnormalities including DWARFISM; PHOTOSENSITIVITY DISORDERS; PREMATURE AGING; and HEARING LOSS. It is caused by mutations of a number of autosomal recessive genes encoding proteins that involve transcriptional-coupled DNA REPAIR processes. Cockayne syndrome is classified by the severity and age of onset. Type I (classical; CSA) is early childhood onset in the second year of life; type II (congenital; CSB) is early onset at birth with severe symptoms; type III (xeroderma pigmentosum; XP) is late childhood onset with mild symptoms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wijnhoven, SW1
Kool, HJ1
van Oostrom, CT1
Beems, RB1
Mullenders, LH1
van Zeeland, AA1
van der Horst, GT1
Vrieling, H1
van Steeg, H1

Other Studies

1 other study available for benzo(a)pyrene and Cockayne Syndrome

ArticleYear
The relationship between benzo[a]pyrene-induced mutagenesis and carcinogenesis in repair-deficient Cockayne syndrome group B mice.
    Cancer research, 2000, Oct-15, Volume: 60, Issue:20

    Topics: Animals; Benzo(a)pyrene; Carcinogens; Cocarcinogenesis; Cockayne Syndrome; Crosses, Genetic; DNA; DN

2000